| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Nurix Therapeutics Inc (NASDAQ: NRIX)
NRIX Technical Analysis
5
| As on 9th Jun 2023 NRIX STOCK Price closed @ 10.14 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 15.28 & Strong Sell for SHORT-TERM with Stoploss of 21.26 we also expect STOCK to react on Following IMPORTANT LEVELS. |
NRIXSTOCK Price
| Open | 10.92 | Change | Price | % |
| High | 10.92 | 1 Day | -0.70 | -6.46 |
| Low | 9.83 | 1 Week | 0.35 | 3.58 |
| Close | 10.14 | 1 Month | 0.03 | 0.30 |
| Volume | 254093 | 1 Year | -18.12 | -64.12 |
| 52 Week High 30.52 | 52 Week Low 7.88 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| NRIX Daily Charts |
NRIX Intraday Charts |
Whats New @ Bazaartrend |
NRIX Free Analysis |
|
|
NRIX Important Levels Intraday
| RESISTANCE | 12.24 |
| RESISTANCE | 11.57 |
| RESISTANCE | 11.15 |
| RESISTANCE | 10.73 |
| SUPPORT | 9.55 |
| SUPPORT | 9.13 |
| SUPPORT | 8.71 |
| SUPPORT | 8.04 |
NRIX Forecast May 2024
| 4th UP Forecast | 35.09 |
| 3rd UP Forecast | 27.09 |
| 2nd UP Forecast | 22.14 |
| 1st UP Forecast | 17.2 |
| 1st DOWN Forecast | 3.08 |
| 2nd DOWN Forecast | -1.86 |
| 3rd DOWN Forecast | -6.81 |
| 4th DOWN Forecast | -14.81 |
NRIX Weekly Forecast
| 4th UP Forecast | 16.90 |
| 3rd UP Forecast | 14.73 |
| 2nd UP Forecast | 13.39 |
| 1st UP Forecast | 12.05 |
| 1st DOWN Forecast | 8.23 |
| 2nd DOWN Forecast | 6.89 |
| 3rd DOWN Forecast | 5.55 |
| 4th DOWN Forecast | 3.38 |
NRIX Forecast2024
| 4th UP Forecast | 57.66 |
| 3rd UP Forecast | 42.42 |
| 2nd UP Forecast | 33 |
| 1st UP Forecast | 23.58 |
| 1st DOWN Forecast | -3.3 |
| 2nd DOWN Forecast | -12.72 |
| 3rd DOWN Forecast | -22.14 |
| 4th DOWN Forecast | -37.38 |
Nurix Therapeutics Inc ( NASDAQ USA Symbol : NRIX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
NRIX Business Profile
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader with immunomodulatory drug (IMiD) activity for the treatment of relapsed or refractory B-cell malignancies; NX-5948, an orally bioavailable BTK degrader without IMiD activity for the treatment of relapsed or refractory B-cell malignancies; and NX-1607, an orally available Casitas B-lineage lymphoma proto-oncogene-B (CBL-B) inhibitor for immuno-oncology indications. It also develops NX-0255, a CBL-B inhibitor for ex vivo use to enhance adoptive T-cell therapy; DeTIL-0255 for tumor infiltrating lymphocytes therapy; KINASE-CTM3 to treat T cell malignancies and autoimmune diseases; and LIGASE-INH2 for immuno-oncology. In addition, the company develops programs, such as COVID-CTM1, COVID-CTM2, and COVID-CTM3 that are designed for protein degradation to SARs CoV2 targets. Nurix Therapeutics, Inc. has a strategic collaboration agreement with Gilead Sciences, Inc. for cancer and other challenging diseases patients; and Sanofi S.A. The company was formerly known as Nurix Inc. and changed its name to Nurix Therapeutics, Inc. in October 2018. Nurix Therapeutics, Inc. was incorporated in 2009 and is headquartered in San Francisco, California. Address: 1700 Owens Street, San Francisco, CA, United States, 94158
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service